Med-X

Growth Stage

Making a Difference, Naturally.

Overview

Raised to Date: Raised: $3,936,422

Total Commitments ($USD)

Platform

Dalmore Group

Start Date

07/23/2021

Close Date

06/30/2023

Min. Goal

$420

Max. Goal

$10,000,000

Min. Investment

$420

Security Type

Equity - Common

Series

Series A

SEC Filing Type

RegA+    Open SEC Filing

Price Per Share

$0.80

Pre-Money Valuation

$102,217,405

Rolling Commitments ($USD)

Status

Active

Reporting Date

03/26/2023

Days Remaining

96

% of Min. Goal

937,243%

% of Max. Goal

39%

Likelihood of Max
unlikely
Avg. Daily Raise

$6,443

# of Investors

1,441

Momentum
cold.svg
Create a free account today to gain access to KingsCrowd analytics.
Year Founded

2014

Industry

Consumer Products, Goods & Services

Tech Sector

Cleantech

Distribution Model

B2B2C

Margin

Medium

Capital Intensity

High

Location

Canoga Park, California

Business Type

Growth

Med-X, with a pre-money valuation of $102 million, is raising funds on Dalmore via Regulation A+. The company has developed many all-natural and plant-based brands that are replacing chemicals to solve everyday issues. The products are sold through major retail and healthcare distributors. The flagship product lines of Med-X include Nature-Cide and Thermal-Aid. Med-X is led by Dr. David Toomey and Matthew Mills and was founded in 2014.

Balance Sheet

Cash and Cash Equivalents

$752,823

Investment Securities

$0

Accounts and Notes Receivable

$150,929

Property, Plant and Equipment (PP&E)

$81,971

Total Assets

$3,081,150

Accounts Payable & Accrued Liabilities

$352,317

Long Term Debt

$1,156,573

Total Liabilities

$2,194,674

Total Stockholders' Equity

$886,476

Total Liabilities and Equity

$3,081,150

Statement of Comprehensive Income Information

Total Revenues

$1,033,750

Costs & Expenses Applicable to Rev

$711,820

Depreciation and Amortization

$115,398

Net Income

$-3,050,009

Earnings Per Share - Basic

$-0.03

Earnings Per Share - Diluted

$-0.03

Auditor: Prager Metis, CPA's LLP
Financials as of: 07/23/2021
Create a free account today to gain access to KingsCrowd analytics.

Raise History

Offering Name Close Date Platform Valuation/Cap Total Raised Security Type Status Reg Type
Med-X 06/30/2023 Dalmore Group $102,217,405 $3,936,422 Equity - Common Active RegA+
Med-X 05/31/2023 PicMii $43,211,544 $0 Equity - Common Active RegCF
Med-X 09/10/2021 TruCrowd $88,552,772 $15,595 Equity - Common Funded RegCF
Med-X 06/27/2019 StartEngine - $7,000,471 Equity - Common Funded RegA+
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$12.42 /month
billed annually
Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings (excluding risk)
Advanced company search ( with ratings)
Markets page filters and historical industry data
Get Edge Annual

Edge Pro

$41.58 /month
billed annually
Full site access including KingsCrowd's qualitative analyst reports.
Plan Includes:
Everything in Edge, plus
Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
Search and filter based on Analyst Reports
In-depth risk ratings for every raise
Get Edge Pro Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Create your first portfolio

Create your very own investment portfolio on KingsCrowd.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Med-X on Dalmore Group 2021
Platform: Dalmore Group
Security Type: Equity - Common
Valuation: $102,217,405

Follow company

Follow Med-X on Dalmore Group 2021
View on Dalmore Group